NorthEast BioLab Logo | Advanced Bioanalytical Services Lab Agile Bioanalytical Services CRO
  • Expertise
    • Menu IconAll Expertise
    • Menu IconMass Spectrometry (LC-MS)
      • Menu IconMass Spectrometry Services
      • Menu IconHPLC Testing Services
    • Menu IconMeso Scale Discovery Assay
    • Menu IconELISA Assay
      • Menu IconLuminex Multiplex Assay
    • Menu IconFlow Cytometry
    • Menu IconqPCR Analysis, ddPCR Assay
    • Menu IconWestern Blot, In Cell Western
  • Services
    • Menu IconAll Services
    • Menu IconPharmacokinetics (PK) Study
      • Menu IconToxicology (Tox) Study
      • Menu IconDose Formulation Analysis
      • Menu IconPK PD Analysis
      • Menu IconDrug Metabolism and Pharmacokinetics (DMPK)
      • Menu IconADME Studies
      • Menu IconBioequivalence and Bioavailability Studies
    • Menu IconADA Assay, Neutralizing Antibody Assay
    • Menu IconMultiplex Cytokine Assay
    • Menu IconBiomarker Assay
      • Menu IconBiomarker Assay List
    • Menu IconCell-Based Assay
      • Menu IconMechanism of Action (MOA) Studies
      • Menu IconCytotoxicity Assay
      • Menu IconBiochemical Assay
    • Menu IconBioanalytical Assay Validation
  • Solutions
    • Menu IconAll Solutions
    • Menu IconClinical CRO
      • Menu IconCentral Lab Services
      • Menu IconPBMC Services
    • Menu IconGLP Laboratory
      • Menu IconBioanalysis
      • Menu IconNon-GLP Testing
    • Menu IconPreclinical CRO
    • Menu IconMethod Development, Validation, And Transfer
      • Menu IconMethod Validation
      • Menu IconMethod Development
      • Menu IconMethod Transfer
    • Menu IconAnalytical Testing
      • Menu IconDiscovery Screening Services
      • Menu IconAnalytical Quantitation
      • Menu IconCosmetic Testing
  • About Us
    • Menu IconAbout Us
    • Menu IconOverview
    • Menu IconLeadership
    • Menu IconFacility and Equipment
    • Menu IconQuality and Compliance
    • Menu IconTherapeutic Areas
    • Menu IconWhy Us?
    • Menu IconValues
    • Menu IconProcess
    • Menu IconPartners
    • Menu IconCareers
      • Business Development Associate
      • Sr. Scientist – Cell Based Assay
      • GLP Quality Assurance Manager
      • Sr. Scientist, ELISA Immunoassay Bioanalysis
      • Sr. Scientist, LC-MS/MS Bioanalysis
      • Associate Scientist, Central Laboratory Services
      • Sr. Scientist - Pharmacokinetics (PK)
      • Content Manager, Scientific and Regulatory Writing
  • Resources
    • Menu IconLearning Center
    • Menu IconBlog
    • Menu IconCase Study
    • Menu IconVideo Brochures
    • Menu IconNews and Events
    • Menu IconTestimonials
    • Menu IconContact Us
  • Request Quote
NorthEast BioLab Logo | Advanced Bioanalytical Services Lab Agile Bioanalytical Services CRO Request Quote

Expertise

  • Menu IconAll Expertise
    • Menu IconMass Spectrometry (LC-MS)
      • Menu IconMass Spectrometry Services
      • Menu IconHPLC Testing Services
    • Menu IconMeso Scale Discovery Assay
      • Menu IconELISA Assay
        • Menu IconLuminex Multiplex Assay
      • Menu IconFlow Cytometry
        • Menu IconqPCR Analysis, ddPCR Assay
          • Menu IconWestern Blot, In Cell Western

            Services

            • Menu IconAll Services
              • Menu IconPharmacokinetics (PK) Study
                • Menu IconToxicology (Tox) Study
                • Menu IconDose Formulation Analysis
                • Menu IconPK PD Analysis
                • Menu IconDrug Metabolism and Pharmacokinetics (DMPK)
                • Menu IconADME Studies
                • Menu IconBioequivalence and Bioavailability Studies
              • Menu IconADA Assay, Neutralizing Antibody Assay
                • Menu IconMultiplex Cytokine Assay
                  • Menu IconBiomarker Assay
                    • Menu IconBiomarker Assay List
                  • Menu IconCell-Based Assay
                    • Menu IconMechanism of Action (MOA) Studies
                    • Menu IconCytotoxicity Assay
                    • Menu IconBiochemical Assay
                  • Menu IconBioanalytical Assay Validation

                    Solutions

                    • Menu IconAll Solutions
                      • Menu IconClinical CRO
                        • Menu IconCentral Lab Services
                        • Menu IconPBMC Services
                      • Menu IconGLP Laboratory
                        • Menu IconBioanalysis
                        • Menu IconNon-GLP Testing
                      • Menu IconPreclinical CRO
                        • Menu IconMethod Development, Validation, And Transfer
                          • Menu IconMethod Validation
                          • Menu IconMethod Development
                          • Menu IconMethod Transfer
                        • Menu IconAnalytical Testing
                          • Menu IconDiscovery Screening Services
                          • Menu IconAnalytical Quantitation
                          • Menu IconCosmetic Testing

                        About Us

                        • Menu IconAbout Us
                          • Menu IconOverview
                            • Menu IconLeadership
                              • Menu IconFacility and Equipment
                                • Menu IconQuality and Compliance
                                  • Menu IconTherapeutic Areas
                                    • Menu IconWhy Us?
                                      • Menu IconValues
                                        • Menu IconProcess
                                          • Menu IconPartners
                                            • Menu IconCareers
                                              • Menu IconBusiness Development Associate
                                              • Menu IconSr. Scientist – Cell Based Assay
                                              • Menu IconGLP Quality Assurance Manager
                                              • Menu IconSr. Scientist, ELISA Immunoassay Bioanalysis
                                              • Menu IconSr. Scientist, LC-MS/MS Bioanalysis
                                              • Menu IconAssociate Scientist, Central Laboratory Services
                                              • Menu IconSr. Scientist - Pharmacokinetics (PK)
                                              • Menu IconContent Manager, Scientific and Regulatory Writing

                                            Resources

                                            • Menu IconLearning Center
                                              • Menu IconBlog
                                                • Menu IconCase Study
                                                  • Menu IconVideo Brochures
                                                    • Menu IconNews and Events
                                                      • Menu IconTestimonials
                                                        • Menu IconContact Us

                                                          Request Quote

                                                            Contact Us

                                                            • Home
                                                            • Incurred Sample Reanalysis, ISR Test, ISR Analysis

                                                            What Is Incurred Sample Reanalysis (ISR)?

                                                            Abhay Pandey | NorthEast BioLab
                                                            By Abhay Pandey, MBA
                                                            Reading Time: 5 minutes
                                                            ISR Lab Test

                                                            Background

                                                            Bioanalytical assays are widely used to quantify drugs and their metabolites in a variety of biological matrices. Incurred sample reanalysis (ISR) has steadily gained popularity as a quality assessment tool for bioanalytical assays. ISR analysis is repeated measurement of analyte within a selected sample set from dosed subjects in separate runs on different days to establish result reproducibility.

                                                            Method validation in pharmacokinetic and bioanalytical studies ensures high quality findings by minimizing bias and error. The validation process includes assessment of selectivity, specificity, sensitivity, accuracy, precision, recovery, and stability of analyte. We conduct these validations on quality control (QC) samples prepared by spiking drug-free matrix from human volunteers or animals with reference compound of known identity and concentration.

                                                            QC samples, however, may not always mimic test compound activity in incurred samples due to several reasons. For example, lack of compound recovery, sample non-homogeneity, metabolite presence, protein binding, and matrix suppression effects etc. Here, Incurred sample reanalysis (ISR) becomes crucial. ISR test involves reanalyzing incurred samples to ensure the accuracy and reliability of the results obtained from the original analysis.

                                                            Scientist Incurred Sample Reanalysis

                                                            Regulation

                                                            First discussions for the need of Incurred sample reanalysis guidelines, prompted by wide variability of reanalyzed samples compared to original results in some studies as observed by FDA, were held in May 2006 at the AAPS / FDA Bioanalytical Workshop entitled “Quantitative Bioanalytical Methods Validation and Implementation: Best Practices for Chromatographic and Ligand Binding Assays”[1]. Afterwards, industry leaders met to discuss general procedures for Incurred sample reanalysis in Feb 2008 at the AAPS/FDA Bioanalytical Workshop entitled “AAPS workshop on current topics in GLP bioanalysis: Assay reproducibility for incurred samples – implications of Crystal City recommendations”, and subsequently published expectations for ISR test conduct, documentation, and reporting in Jun 2009[2]. European Medicines Agency first provided regulatory guidance on ISR analysis. FDA followed in 2013 through publishing of its own draft document.

                                                            FDA’s ISR Mandate

                                                            • Require Incurred Sample Reanalysis (ISR) for all pivotal PK / PD and in vivo human BE studies; ISR at least once for each method and species during non-clinical safety studies
                                                            • Incorporate ISR analysis into method development and validation pilot to allow for remediation prior to pivotal study; monitor Incurred sample reanalysis in larger number and variety for pivotal PK / PD studies
                                                            • Select up to 10% of study samples for the ISR test
                                                            • Sample selection to ensure adequate coverage of entire PK / PD profile of all subjects, including assessments from time points around Cmax and end of elimination phase
                                                            • Analyze using the original bioanalytical method (including number of replicates and any applied dilution factor), and compare Incurred sample reanalysis samples to freshly prepared calibrators
                                                            • At least two-thirds (67%) of ISR test results should be within 20% of original results for small molecules and within 30% of original results for large molecules; percentage difference calculated as (Repeat – Original)*100 / Mean
                                                            • No regulatory requirement for additional analyses, if an individual sample does not meet the above acceptance criteria; scientific judgment expected in case difference is substantial
                                                            • Halt analyses and perform / document investigation, if overall Incurred sample reanalysis does not meet acceptance criteria
                                                            • Document all ISR tests evaluations to reconstruct the study conduct and any follow up investigations

                                                            ISR Analysis

                                                            Study

                                                            We conducted ISR analysis on a chemotherapy drug Capecitabine used in treatment of many types of cancers, such as breast, colon, rectal, stomach, oesophageal and pancreatic cancers. The subject drug is rationally designed 5-fluorouracil (FU) prodrug that mimics continuous infusion of 5-FU while avoiding complications / inconvenience of intravenous administration. This antimetabolite drug gets absorbed intact from the gastrointestinal tract, converted enzymatically to active 5-FU, and released directly into the tumour. Therefore, accurate measurement of 5-FU through Incurred sample reanalysis is an essential study.[3]

                                                            We measured both Capecitabine and its metabolite 5-FU. For sample preparation, we put together standards and QCs containing both the analytes and internal standards. Our analysts ran separate LC-MS/MS for the two analytes due to significant retention time difference. Initially, ISR analysis passed for the parent but failed for the metabolite

                                                            During the ISR test, we noticed that the current bioanalytical method can accurately measure Capecitabine but the observed 5-FU levels were highly variable. Therefore, we initiated an investigation to find out the cause for this high variability and increased concentration of 5-FU. Note that the prodrug does not metabolizes to 5-FU directly, but goes through intermediate metabolism, as noted.

                                                            Capecitabine à 5’-deoxy-5-fluorocytidine (5’-DFCR) à 5’-deoxy-5-fluorourindine (5’-DFUR) à 5-FU
                                                            Additionally, there are specific enzymes involved in all the transformations

                                                            • Carboxylesterase in the liver (5’–DFCR)
                                                            • Cytidine deaminase in the liver and tumor tissue (5’-DFUR)
                                                            • Thymidine phosphorylase (TP) in tumor tissue (5-FU)

                                                            Hence, it was necessary to measure other intermediate metabolites to understand the issue. We performed several experiments to deduce the reason for 5-FU Incurred sample reanalysis failure. This was primarily due to further conversion of other intermediate metabolites to 5-FU as well, resulting in its way higher concentrations during the ISR test.

                                                            ISR Clinical Samples

                                                            Conclusion

                                                            We noted that Capecitabine and 5’DFCR are unstable in blood and in plasma on Ice and 37oC. 5’DFUR is unstable in blood but stable in plasma. Furthermore, we observed an increase in concentration of 5’DFUR in plasma suggesting conversion from Capecitabine and 5’DFCR. Thus, we infer that multiple mechanisms must be contributing towards the increase in concentration of 5-FU in clinical samples. Hence in-vivo a positive bias towards 5-FU is possible due to instability of Capecitabine and the other intermediate metabolites.

                                                            NorthEast Biolab supports ISR for both preclinical and clinical studies. Our ISR recommendations include First-in-human, First-in-patient, Drug–drug interaction, impaired population, Bioequivalence/Biocomparability, First-time method use, and pivotal studies. Our team follows Standard Operating Procedures (SOPs) to conduct, report, and investigate ISR findings. We review and update these SOPs regularly to meet regulatory and client expectations and provide reliable, high-quality data.

                                                            [1] Viswanathan CT1, Bansal S, Booth B, DeStefano AJ, Rose MJ, Sailstad J, Shah VP, Skelly JP, Swann PG, Weiner R, Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays, Pharm Res. 2007 Oct;24(10):1962-73. Epub 2007 Apr 26

                                                            [2] Fast DM, Kelley M, Viswanathan CT, O’Shaughnessy J, King SP, Chaudhary A, Weiner R, DeStefano AJ, Tang D, Workshop report and follow-up–AAPS Workshop on current topics in GLP bioanalysis: Assay reproducibility for incurred samples–implications of Crystal City recommendations, AAPS J. 2009 Jun;11(2):238-41. doi: 10.1208/s12248-009-9100-9. Epub 2009 Apr 21.

                                                            [3] Chintala, L., Vaka, S., Baranda, J. et al. Oncol Rev (2011) 5: 129. https://doi.org/10.1007/s12156-011-0074-3

                                                            Registered And Inspected By Various Regulatory Agencies

                                                            • Good Laboratory Practice for Nonclinical Laboratory Studies
                                                            • Food and Drug Administration (FDA)
                                                            • Clinical Laboratory Improvement Amendments | NorthEast BioLab
                                                            • International Orgaization for Standardization |NorthEast BioLab
                                                            • DEA
                                                            • DOCP

                                                            Speak To Our Scientist About Your Incurred Sample Reanalysis (ISR) Test Challenges

                                                            SPEAK TO OUR SCIENTISTS

                                                            Similar Case Study Articles

                                                            • Inflammatory Biomarker Multiplex

                                                              Multiplex Cytokine Assay, GLP Cytokine Validation, Cytokine Quantification On MSD

                                                            • Humanized Monoclonal Antibody (MAb) PK ELISA Development, GLP Validation, And MAb Bioanalysis

                                                            • Oligonucleotide Hybridization ELISA PK Assay, GLP Validation, Sample Analysis

                                                            • TaqMan Gene Expression Assay, Copy Number Variation

                                                            • Genomic Variation Analysis – TaqMan Single Nucleotide Polymorphism (SNP) Analysis

                                                            • LC MS Bioanalysis Of Oligos Using Mass Spec And Ion Pair Chromatography

                                                            • Dosing THC Lab, Cannabis Testing Lab, CBD Melatonin Testing

                                                            • HPLC-UV Method Development: Testing 9 Articles in Formulation

                                                            • Payload Plus Peptide LC MS Analysis, GLP Validation In Rat, NHP, Human Plasma

                                                            • Epigallocatechin gallate (EGCG) LC MS Analysis In VcEDTA Human Serum

                                                            • LC MS Method For Proline Amino Acid, Hydroxyproline In Mouse Tissues

                                                            • LC MS Method For DNA Adducts Analysis In Cell-Based In-Vitro Samples

                                                            • LC MS Method for Everolimus Eluting Coronary Stent Drug Delivery Systems

                                                            • Mass Spectrometry Amino Acids, Quantitative LC MS Amino Acid Analysis

                                                            • LC MS Method Development And GLP Validation For PK Plasma Sample Analysis

                                                            • DBS Test

                                                              Dried Blood Spot (DBS) Sampling, DBS Collection, And DBS Analysis

                                                            Explore Our Expertise

                                                            • Mass Spectrometry (LC-MS)

                                                            • Meso Scale Discovery Assay

                                                            • ELISA Assay

                                                            • Flow Cytometry

                                                            • qPCR Analysis, ddPCR Assay

                                                            • Western Blot, In Cell Western

                                                            Contact A Scientist With Your Bioanalytical Study Details

                                                            We Will Respond Within 1 Business Day

                                                            Expertise

                                                            Expertise

                                                            • Mass Spectrometry (LC-MS)
                                                            • Meso Scale Discovery Assay
                                                            • ELISA Assay
                                                            • Flow Cytometry
                                                            • qPCR Analysis, ddPCR Assay
                                                            • Western Blot, In Cell Western

                                                            Services

                                                            Services

                                                            • Pharmacokinetics (PK) Study
                                                            • ADA Assay, Neutralizing Antibody Assay
                                                            • Multiplex Cytokine Assay
                                                            • Biomarker Assay
                                                            • Cell-Based Assay
                                                            • Bioanalytical Assay Validation

                                                            Solutions

                                                            Solutions

                                                            • Clinical CRO
                                                            • GLP Laboratory
                                                            • Preclinical CRO
                                                            • Method Development, Validation, And Transfer
                                                            • Analytical Testing

                                                            About Us

                                                            About Us

                                                            • Overview
                                                            • Leadership
                                                            • Facility and Equipment
                                                            • Quality and Compliance
                                                            • Therapeutic Areas
                                                            • Why Us?
                                                            • Values
                                                            • Process
                                                            • Partners
                                                            • Careers

                                                            Resources

                                                            Resources

                                                            • Learning Center
                                                            • Blog
                                                            • Case Study
                                                            • Video Brochures
                                                            • News and Events
                                                            • Testimonials
                                                            • Contact Us
                                                            NorthEast BioLab Logo Agile Bioanalytical Services CRO
                                                            sales@nebiolab.comFollow Up On Email
                                                            (203) 361 3780Follow Up On Phone

                                                            35 Worth Ave, Hamden, CT 06518

                                                            • Good Laboratory Practice for Nonclinical Laboratory Studies | NorthEast BioLab
                                                            • Food and Drug Administration (FDA | NorthEast BioLab
                                                            • clia
                                                            • United States Drug Enforcement Administration | NorthEast BioLab
                                                            • Department of Consumer Protection | NorthEast BioLab
                                                            • Privacy Policy
                                                            • Terms of Use
                                                            • Sitemap
                                                            All rights reserved.